Background High-risk febrile neutropenia (HR-FN) is a life-threatening complication in patients with haematological malignancies or receiving myelosuppressive chemotherapy …
A Vena, M Schenone, S Corcione… - Journal of …, 2024 - academic.oup.com
Objectives To determine the association of adequate empirical combination therapy (AECT) with 30-day all-cause mortality in patients with septic shock due to Pseudomonas …
C Royo-Cebrecos, J Laporte-Amargós, M Peña… - Pathogens, 2022 - mdpi.com
Objectives: To assess the clinical features and outcomes of Pseudomonas aeruginosa bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies …
M Chumbita, P Puerta-Alcalde, L Yáñez… - Microbiology …, 2023 - Am Soc Microbiol
Optimal coverage of Pseudomonas aeruginosa is challenging in febrile neutropenic patients due to a progressive increase in antibiotic resistance worldwide. We aimed to detail current …
CJ Hunter, EA Marhoffer, JL Holleck… - Journal of …, 2024 - academic.oup.com
Background Empiric antibiotics active against Pseudomonas aeruginosa are recommended by professional societies for certain infections and are commonly prescribed for hospitalized …
AA Heydari, S Jamialahmadi… - Jundishapur Journal of …, 2022 - brieflands.com
Background: Pseudomonas aeruginosa is an opportunistic gram-negative pathogen that can cause infection in almost any body part. Objectives: We aimed to evaluate the …
Introdução: Aminoglicosídeos são antimicrobianos bactericidas que apresentam grande atividade para bactérias gram-negativas aeróbias, o que torna esses medicamentos …
C Royo-Cebrecos, J Laporte-Amargós, M Peña… - 2024 - pdfs.semanticscholar.org
This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among …
[spa] La neutropenia febril (NF) en los pacientes oncohematológicos representa uno de los desafíos clínicos más significativos en la medicina. Del mismo modo, poblaciones …